News
Archive
NorthSea Therapeutics to present ICONA Phase 2b data as an oral late-breaker session at the 2023 AASLD Liver Meeting
Zeotap Data offers digital media buyers precision and reach against their core demographic audiences. Validated with persistent, factual data, accuracy far exceeds big tech DSPs
Ventyx Biosciences announces results from the Phase 2 trial of VTX958 in patients with moderate to severe plaque psoriasis and provides corporate update
NorthSea Therapeutics receives FDA Rare Pediatric Disease Designation for SEFA-6179 for the treatment of Intestinal Failure-Associated Liver Disease
Glydways announces $56 Million Series B Round with New Science Ventures, ACS Group, Khosla Ventures and Gates Frontier
Paragraf named Business of the Year in Cambridge glory parade
Back To News
November 1, 2017
Big Data: Drilling for value
Data in the 21st Century is like Oil in the 18th Century: an immensely, untapped valuable asset, according to Wired, amongst others. Like oil, for those who see data’s fundamental value and learn to extract and use it there will be huge rewards. And, indeed for some time now, the lure of big data has been a … Continue reading “Big Data: Drilling for value”
The post Big Data: Drilling for value appeared first on Fuzzy Logix.